title: Current clinical trial design issues in hormone-refractory prostate carcinoma. Consensus Panel.
authors.forename: N J
authors.initials: NJ
authors.lastname: Vogelzang
authors.forename: E D
authors.initials: ED
authors.lastname: Crawford
authors.forename: A
authors.initials: A
authors.lastname: Zietman
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000628:therapy*; D012107:Research Design
chemical_list: D000726:Androgen Antagonists; D017430:Prostate-Specific Antigen